Accordingly, our ex vivo assays of blood leukocytes indicated an increased proportion of cells expressing IL-17, not only CD4+ lymphocytes but also neutrophils, a population activated in SLE and able to produce this molecule in pathological conditions44, 45. This evidence concerns the gene CD4 and systemic lupus erythematosus.